Literature DB >> 28876296

Neighborhood Health Care Access and Sexually Transmitted Infections Among Women in the Southern United States: A Cross-Sectional Multilevel Analysis.

Danielle F Haley, Andrew Edmonds, Nadya Belenky, DeMarc A Hickson, Catalina Ramirez, Gina M Wingood, Hector Bolivar, Elizabeth Golub, Adaora A Adimora.   

Abstract

INTRODUCTION: The United States has experienced an increase in reportable sexually transmitted infections (STIs) while simultaneously experiencing a decline in safety net services for STI testing and treatment. This multilevel study assessed relationships between neighborhood-level access to health care and STIs among a predominantly Human Immunodeficiency Virus (HIV)-seropositive cohort of women living in the south.
METHODS: This cross-sectional multilevel analysis included baseline data from HIV-seropositive and HIV-seronegative women enrolled in the Women's Interagency HIV Study sites in Alabama, Florida, Georgia, Mississippi, and North Carolina between 2013 and 2015 (N = 666). Administrative data (eg, United States Census) described health care access (eg, percentage of residents with a primary care provider, percentage of residents with health insurance) in the census tracts where women lived. Sexually transmitted infections (chlamydia, gonorrhea, trichomoniasis, or early syphilis) were diagnosed using laboratory testing. Generalized estimating equations were used to determine relationships between tract-level characteristics and STIs. Analyses were conducted using SAS 9.4.
RESULTS: Seventy percent of participants were HIV-seropositive. Eleven percent of participants had an STI. A 4-unit increase in the percentage of residents with a primary care provider was associated with 39% lower STI risk (risk ratio, 0.61, 95% confidence interval, 0.38-0.99). The percentage of tract residents with health insurance was not associated with STIs (risk ratio, 0.98, 95% confidence interval, 0.91-1.05). Relationships did not vary by HIV status.
CONCLUSIONS: Greater neighborhood health care access was associated with fewer STIs. Research should establish the causality of this relationship and pathways through which neighborhood health care access influences STIs. Structural interventions and programs increasing linkage to care may reduce STIs.

Entities:  

Mesh:

Year:  2018        PMID: 28876296      PMCID: PMC5726943          DOI: 10.1097/OLQ.0000000000000685

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  26 in total

1.  Does funding for HIV and sexually transmitted disease prevention matter? Evidence from panel data.

Authors:  Harrell W Chesson; Paul Harrison; Carol R Scotton; Beena Varghese
Journal:  Eval Rev       Date:  2005-02

2.  Local public health systems and the incidence of sexually transmitted diseases.

Authors:  Hector P Rodriguez; Jie Chen; Kwame Owusu-Edusei; Allen Suh; Betty Bekemeier
Journal:  Am J Public Health       Date:  2012-07-19       Impact factor: 9.308

3.  The impact of health care market changes on local decision making and STD care: experience in three counties.

Authors:  A M Kimball; W E Lafferty; W J Kassler; A Hundt; R MacCornack; G Bolan
Journal:  Am J Prev Med       Date:  1997 Nov-Dec       Impact factor: 5.043

4.  The occurrence of vaginal infections among HIV-infected and high-risk HIV-uninfected women: longitudinal findings of the women's interagency HIV study.

Authors:  D Heather Watts; Gayle Springer; Howard Minkoff; Sharon L Hillier; Lisa Jacobson; Michael Moxley; Jessica Justman; Helen Cejtin; Casey O'Connell; Ruth M Greenblatt
Journal:  J Acquir Immune Defic Syndr       Date:  2006-10-01       Impact factor: 3.731

5.  Bacterial sexually transmitted infections among HIV-infected patients in the United States: estimates from the Medical Monitoring Project.

Authors:  Elaine W Flagg; Hillard S Weinstock; Emma L Frazier; Eduardo E Valverde; James D Heffelfinger; Jacek Skarbinski
Journal:  Sex Transm Dis       Date:  2015-04       Impact factor: 2.830

6.  Retention and attendance of women enrolled in a large prospective study of HIV-1 in the United States.

Authors:  Nancy A Hessol; Kathleen M Weber; Susan Holman; Esther Robison; Lakshmi Goparaju; Christine B Alden; Naoko Kono; D Heather Watts; Niloufar Ameli
Journal:  J Womens Health (Larchmt)       Date:  2009-10       Impact factor: 2.681

7.  Applying the Gelberg-Andersen behavioral model for vulnerable populations to health services utilization in homeless women.

Authors:  Judith A Stein; Ronald Andersen; Lillian Gelberg
Journal:  J Health Psychol       Date:  2007-09

8.  Correlates of hospital use in homeless and unstably housed women: the role of physical health and pain.

Authors:  Kelly M Doran; Martha Shumway; Rani A Hoff; Oni J Blackstock; Samantha E Dilworth; Elise D Riley
Journal:  Womens Health Issues       Date:  2014 Sep-Oct

9.  Continuing Need for Sexually Transmitted Disease Clinics After the Affordable Care Act.

Authors:  Karen W Hoover; Bradley W Parsell; Jami S Leichliter; Melissa A Habel; Guoyu Tao; William S Pearson; Thomas L Gift
Journal:  Am J Public Health       Date:  2015-10-08       Impact factor: 9.308

Review 10.  A systematic review of publications assessing reliability and validity of the Behavioral Risk Factor Surveillance System (BRFSS), 2004-2011.

Authors:  Carol Pierannunzi; Shaohua Sean Hu; Lina Balluz
Journal:  BMC Med Res Methodol       Date:  2013-03-24       Impact factor: 4.615

View more
  2 in total

1.  The Black-White Disparity in Sexually Transmitted Diseases During Pregnancy: How Do Racial Segregation and Income Inequality Matter?

Authors:  Aggie J Noah; Tse-Chuan Yang; Wei-Lin Wang
Journal:  Sex Transm Dis       Date:  2018-05       Impact factor: 2.830

Review 2.  Collateral Damage: A Narrative Review on Epidemics of Substance Use Disorders and Their Relationships to Sexually Transmitted Infections in the United States.

Authors:  Steffanie Ann Strathdee; Claire C Bristow; Tommi Gaines; Steven Shoptaw
Journal:  Sex Transm Dis       Date:  2021-07-01       Impact factor: 3.868

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.